Top 10: Endocrinology Network 2016

Slideshow

SGLT2 inhibitors, GLP-1 receptor agonists, insulin, and more – we’ve compiled a list of this year’s most popular articles on Endocrinology Network.

We’ve compiled a list of our readers’ favorite 10 articles in 2016.

Recent Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Alexandra Louise Møller, MS, PhD | Credit: LinkedIn
A panel of 5 experts on Cushing's syndrome
A panel of 5 experts on Cushing's syndrome
Optimizing Diabetes Therapies with New Classifications
Vlado Perkovic, MBBS, PhD | Credit: George Institute of Global Health
Should We Reclassify Diabetes Subtypes?
Related Content
Alie Rezaie, MD | Credit: Cedars-Sinai

Surge in New GLP-1 Prescriptions Driven by Semaglutide's Popularity, Study Shows

Patrick Campbell
July 22nd 2024
Article
John Buse, MD, PhD | Credit: UNC School of Medicine

Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 15th 2024
Podcast
FDA Issues CRL to Once-Weekly Insulin Icodec | Image Credit: US Food and Drug Administration

FDA Issues Complete Response Letter for Once-Weekly Insulin Icodec

Connor Iapoce
July 11th 2024
Article
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diabetes Dialogue: ADA 2024 Diabetes Technology Recap

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES;Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
July 3rd 2024
Podcast
Brendon Neuen, MBBS, PhD | Credit: X.com

SGLT2 Inhibitor, GLP-1 RA Combination Improves Cardiovascular, Kidney Outcomes in Diabetes

Abigail Brooks, MA
July 9th 2024
Article
Nicholas Stucky, MD, PhD | Credit: LinkedIn

Tirzepatide Bests Semaglutide in Real-World Weight Loss Analysis

Patrick Campbell
July 8th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.